MedTrace Logo

The Effect of Marijuana and Prescription Medications in Mood, Performance and Sleep

NCT00893269 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2013-12-05

No results posted yet for this study

Summary

Heavy marijuana users report experiencing trouble sleeping when they try to quit, but this has not been carefully studied. This research is being done to learn more about sleep function in heavy marijuana users, and to determine whether a medication approved for treating insomnia can help restore normal sleep function during brief periods of abstinence.

Conditions

  • Marijuana Dependence

Interventions

DRUG

eszopiclone

Oral capsule at dose recommended for adults

DRUG

Placebo

Participants receive placebo prior to sleep

DRUG

ramelteon

ramelteon

DRUG

zolpidem

zolpidem

Sponsors & Collaborators

  • Food and Drug Administration (FDA)

    collaborator FED

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Johns Hopkins University

    lead OTHER

Principal Investigators

  • Ryan Vandrey, Ph.D. · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00893269 on ClinicalTrials.gov